|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM XEROX CORPORATION'S 9-30-00 FINANCIAL STATEMENTS AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<CASH> 154
<SECURITIES> 0
<RECEIVABLES> 16057
<ALLOWANCES> 571
<INVENTORY> 3108
<CURRENT-ASSETS> 12145
<PP&E> 5499
<DEPRECIATION> 3000
<TOTAL-ASSETS> 29283
<CURRENT-LIABILITIES> 7522
<BONDS> 17197
638
659
<COMMON> 669
<OTHER-SE> 3382
<TOTAL-LIABILITY-AND-EQUITY> 29283
<SALES> 7192
<TOTAL-REVENUES> 13581
<CGS> 4266
<TOTAL-COSTS> 8287
<OTHER-EXPENSES> 5679
<LOSS-PROVISION> 316
<INTEREST-EXPENSE> 739
<INCOME-PRETAX> (385)
<INCOME-TAX> (93)
<INCOME-CONTINUING> (265)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (265)
<EPS-BASIC> (0.44)
<EPS-DILUTED> (0.44)
</TABLE>
|
|